Foclivia is a vaccine used in adults to protect against flu when a ‘pandemic’ has been officially declared by the World Health Organization (WHO) or the European Union (EU). A flu pandemic occurs when a new type (strain) of flu virus can spread easily from person to person because people have no immunity (protection) against it. A pandemic can affect most countries and regions around the world. Foclivia would be given according to official recommendations. Foclivia contains some parts of inactivated (killed) influenza (flu) virus. It contains a flu strain called A/Vietnam/1194/2004 (H5N1).
Therapeutic Indication
### Therapeutic indication Prophylaxis of influenza in an officially declared pandemic situation. Pandemic influenza vaccine should be used in accordance with official guidance.
Therapeutic Area (MeSH)
N/AATC Code
J07BB02
ATC Item
influenza, inactivated, split virus or surface antigen
Pharmacotherapeutic Group
Influenza vaccines
Active Substance (Summary)
INN / Common Names
N/A| Substance | CAS | Monograph |
|---|---|---|
| influenza virus surface antigens, inactivated: A/Viet Nam/1194/2004 (H5N1) | N/A | influenza virus surface antigens, inactivated: a/viet nam/1194/2004 (h 5 n 1) |
EMA Name
Foclivia
Medicine Name
Foclivia
Aliases
N/ANo risk management plan link.
